Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-22
    E.g., 2018-09-22

Articles

12317 items
7:48 PM, Sep 11, 2018  |  BC Extra | Financial News

With clear regulatory path, Endocyte raises $175M

Endocyte Inc. (NASDAQ:ECYT) raised $175 million through the sale of 9.5 million shares at $18.50 in a follow-on underwritten by Jefferies, Wells Fargo, RBC Capital Markets and Wedbush. The price was a 2% discount to...
3:22 PM, Sep 11, 2018  |  BC Extra | Financial News

OncoResponse to move into clinic with $40M series B

OncoResponse Inc. (Houston, Texas) raised $40 million in a series B round led by RiverVest Venture Partners. Fellow new investors Qatar Investment Authority and Redmile Group participated, as did existing investors Alexandria Venture Investments, Arch...
1:23 PM, Sep 11, 2018  |  BC Extra | Financial News

Vivo closes $635M life sciences fund

Vivo Capital said it closed its oversubscribed Vivo Opportunity Fund with $635 million. The long-only public equity fund plans to invest in small to mid-cap companies through follow-ons, private placements, IPOs and block trades. Vivo’s Albert...
7:07 PM, Sep 09, 2018  |  BC Extra | Financial News

With anti-VEGF challenger in clinic, Kodiak files for IPO

Ophthalmic company Kodiak Sciences Inc. (Palo Alto, Calif.) filed to raise $100 million in an IPO on NASDAQ underwritten by Morgan Stanley, BofA Merrill Lynch, Barclays and Chardan. Using its antibody biopolymer conjugate (ABC) platform, Kodiak...
4:20 PM, Sep 07, 2018  |  BC Extra | Financial News

Opko's Frost among those charged in ‘pump-and-dump’ schemes

The SEC filed charges against biotech investor and former Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Chairman Phillip Frost alleging that he participated in “pump-and-dump” schemes involving penny stock companies. Frost, who is chairman and CEO at...
12:06 PM, Sep 07, 2018  |  BC Extra | Financial News

RNAi company Dicerna raises $100M follow-on

Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) gained $1.79 (14%) to $14.81 on Friday after raising $100 million via the sale of 7.7 million shares at $13.02 in a follow-on underwritten by Citigroup, Leerink, Stifel, H.C. Wainwright and...
7:57 AM, Sep 07, 2018  |  BC Extra | Financial News

After shares spike, ProQR raises $90.6M in upsized offering

ProQR Therapeutics N.V. (NASDAQ:PRQR) raised $90.6 million through the sale of 5.8 million shares at $15.75 in a bumped-up follow-on underwritten by Citigroup, Evercore ISI, RBC Capital Markets, H.C. Wainwright and Chardan. ProQR gained 121% on...
5:28 AM, Sep 07, 2018  |  BC Extra | Financial News

SCM raises $35M series C for stem cells to treat inflammation

SCM Lifescience (Incheon, South Korea) closed a $35 million series C round from 15 investors last Friday to advance its pipeline of disease-specific mesenchymal stem cell therapies. Seoul-based investors DS Asset Management and Neoplux contributed the...
2:22 PM, Sep 06, 2018  |  BC Extra | Financial News

Non-coding RNA company Twentyeight-Seven debuts with $65M

Twentyeight-Seven Therapeutics Inc. (Cambridge, Mass.) raised $65 million in a series A co-led by MPM Capital and Novartis Venture Fund. Johnson & Johnson Innovation-JJDC Inc., Vertex Ventures HC, Longwood Fund and Astellas Venture Management also...
1:16 PM, Sep 06, 2018  |  BC Extra | Financial News

Allogene raises $120M in convertible notes

Just a few months after raising $300 million in a series A round, cell therapy company Allogene Therapeutics Inc. (South San Francisco, Calif.) raised $120 million through the sale of convertible notes. Perceptive Advisors led...

Pages